zintick

Idexx Laboratories IDXX

Idexx Laboratories Inc /DE · Nasdaq · In Vitro & In Vivo Diagnostic Substances

$671.64+21.85%close on Nov. 2, 2026 · volume 1.9M · Yahoo Finance

Price, last 50 sessions

$550.00$600.00$650.00Sept. 2026Oct. 2026Nov. 2026
Aug. 24, 2026 to Nov. 2, 2026 · high $671.64 · low $504.70 · SEC filing, placed when SEC released it

Our coverage

Nothing published yet.

Insider buying and selling

DateInsiderTradeSharesAvg. priceValue
Sept. 4, 2026Lawrence D. Kingsley
director
Sold2,203$532.08$1.17 million

Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.

Recent SEC filings

All 8 →
  • 8-KNov. 2, 2026, 6:30 a.m. ETView on SEC.gov

    Results of operations and financial condition · Financial statements and exhibits

    AI summary, unreviewedIDEXX Laboratories beats Q3 2026 estimates with EPS of $4.01 and revenue of $1.21 billion; raises 2026 revenue and EPS guidance

  • 10-QNov. 2, 2026, 4:29 p.m. ETView on SEC.gov
  • SCHEDULE 13GOct. 30, 2026, 1:54 p.m. ETView on SEC.gov
  • 4Sept. 9, 2026, 5 p.m. ETView on SEC.gov
  • 4Aug. 24, 2026, 5 p.m. ETView on SEC.gov
  • 8-KAug. 4, 2026, 6:32 a.m. ETView on SEC.gov

    Results of operations and financial condition · Financial statements and exhibits

  • 10-QAug. 4, 2026, 4:16 p.m. ETView on SEC.gov
  • 4Aug. 3, 2026, 5 p.m. ETView on SEC.gov